Kong Rong Pan
Chief Operating Officer presso PEIJIA MEDICAL LIMITED
Profilo
Kong Rong Pan is currently the Chief Operating Officer at Peijia Medical Technology (Suzhou) Co., Ltd.
and Peijia Medical Ltd.
He previously worked as the Senior Vice President-Manufacturing & Operation at MicroPort Scientific Corp.
and as the Senior Vice President-Supply Chain at Shanghai Microport Medical (Group) Co., Ltd.
Mr. Pan received his undergraduate degree from Beihang University, his graduate degree from Shanghai University of Technology, and two graduate degrees from The Curtis L.
Carlson School of Management.
Posizioni attive di Kong Rong Pan
Società | Posizione | Inizio |
---|---|---|
PEIJIA MEDICAL LIMITED | Chief Operating Officer | - |
Peijia Medical Technology (Suzhou) Co. Ltd.
Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | Chief Operating Officer | 01/08/2017 |
Precedenti posizioni note di Kong Rong Pan
Società | Posizione | Fine |
---|---|---|
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | Corporate Officer/Principal | 01/12/2015 |
MICROPORT SCIENTIFIC CORPORATION | Chief Operating Officer | - |
Formazione di Kong Rong Pan
Beihang University | Undergraduate Degree |
Shanghai University of Technology | Graduate Degree |
The Curtis L. Carlson School of Management | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
MICROPORT SCIENTIFIC CORPORATION | Health Technology |
PEIJIA MEDICAL LIMITED | Health Technology |
Aziende private | 2 |
---|---|
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | Electronic Technology |
Peijia Medical Technology (Suzhou) Co. Ltd.
Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | Health Technology |
- Borsa valori
- Insiders
- Kong Rong Pan